New Drug Fights Prostate Cancer - KTVN Channel 2 - Reno Tahoe News Weather, Video -

New Drug Fights Prostate Cancer

Posted: Updated:
  • Wendy Damonte's Health Watch ReportsMore>>

  • Request Remind Me 2 Kit

    Request a Remind Me 2 Kit

         More >>
  • Implanted Defibrillators

    Implanted Defibrillators

    Thursday, July 31 2014 5:24 PM EDT2014-07-31 21:24:50 GMT
    More and more companies are buying external defibrillators. They talk you through how to shock someone's heart that has gone into sudden cardiac death. But there are also defibrillators you can implant into a high risk patient. And now that technology has taken another step forward.More >>
    More and more companies are buying external defibrillators. They talk you through how to shock someone's heart that has gone into sudden cardiac death. But there are also defibrillators you can implant into a high risk patient. And now that technology has taken another step forward.More >>
  • AB Donors Urgently Needed at United Blood Services

    AB Donors Urgently Needed at United Blood Services

    Thursday, July 31 2014 4:57 PM EDT2014-07-31 20:57:36 GMT
    United Blood Services of Reno is in urgent need of AB Plasma donors. AB Plasma is the universal plasma blood type meaning all hospital patients can receive an AB Plasma transfusion when plasma is required on a moments notice to save lives.More >>
    United Blood Services of Reno is in urgent need of AB Plasma donors. AB Plasma is the universal plasma blood type meaning all hospital patients can receive an AB Plasma transfusion when plasma is required on a moments notice to save lives.More >>

An experimental drug can help men with advanced prostate cancer live longer A new study published in the New England Journal of Medicine shows the drug enzalutamide can significantly extend life and improve its quality for men with advanced disease.

"There was a 4, 5 month increase in life in the men who got this drug versus the men who did not," says Dr. Erik Goluboff of Beth Israel Medical Center.

The drug blocks testosterone from stimulating prostate cancer cells. Researchers found it was so successful, they stopped the study and offered the treatment to the patients that were not taking it.

A second study finds that measuring the PSA levels in men between the ages of 55 and 69 could lead to fewer deaths from prostate cancer. But treating the cancer too early and to aggressively would have a big impact on the quality of a patient's life.

"This gain in um in years lived is discounted by the fact that many of these men had complications from their treatment."

Complications can include erectile dysfunction and incontinence. A federal task force has recommended against giving the PSA test, saying that routine screening often leads to tests and treatment that can be unnecessary and harmful.

64-year-old Eduardo Cruz is holding off treating his early prostate cancer for that reason.

"The doctor is just waiting to see if the cancer grows or becomes more aggressive then he we'll treat it."

He trusts his doctor to help him weigh the risks and benefits and make the best decision.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Sarkes Tarzian, Inc. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.